NCT06083207
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06083207
Title A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Wollongong Private Hospital SUSPENDED Wollongong New South Wales 2500 Australia Details
Austin Hospital SUSPENDED Heidelberg Victoria 3084 Australia Details
St Vincent's Hospital SUSPENDED Melbourne Victoria 3065 Australia Details
Peking Union Medical College Hospital NOT_YET_RECRUITING Beijing Beijing Municipality 100730 China Details
The first Affiliated Hospital of Guangxi Medical University NOT_YET_RECRUITING Nanning Guangxi 530021 China Details
Tongji Medical College of HUST Tongji Hospital RECRUITING Wuhan Hubei 430030 China Details
Jiangsu Province Hospital NOT_YET_RECRUITING Nanjing Jiangsu 210029 China Details
The First Affiliated Hospital of Soochow University NOT_YET_RECRUITING Suzhou Jiangsu 215006 China Details
The Affiliated Hospital of Xuzhou Medical University RECRUITING Xuzhou Jiangsu 221002 China Details
Jiangxi Cancer Hospital NOT_YET_RECRUITING Nanchang Jiangxi 330029 China Details
ZhongShan Hospital FuDan University RECRUITING Shanghai Shanghai Municipality 201700 China Details
The First Affiliated Hospital of XI'AN Jiaotong University NOT_YET_RECRUITING Xian Shanxi 710061 China Details
Tianjin Medical University General Hospital NOT_YET_RECRUITING Tianjin Tianjin Municipality 300050 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field